OLT1177 Gel

dapansutrile · Olatec Therapeutics LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OLT1177 Gel, covering 2014-10-06 to 2017-10-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain [Phase 2]